Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Positive flurpiridaz data will likely increase cardiac PET | Tricuspid therapies moving ahead of mitral seeking FDA approval
Monday, September 12, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Flurpiridaz data shows promise to expand and enhance cardiac PET

The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) PET radiotracer agent.

READ MORE >
Comparison of flurpiridaz F-18 PET, SPECT and angiography of the 60-year-old female patients in the Aurora trial. The SPECT scan appeared normal, but flurpiridaz was shown to be more sensitive and showed the ischemia from two blockages in the right coronary artery. The new radiotracer may help expand cardiac PET. #ASNC
Share on Twitter Share on Facebook Share on Linkedin

Flurpiridaz data shows promise to expand and enhance cardiac PET

Share on Twitter Share on Facebook Share on Linkedin
Comparison of flurpiridaz F-18 PET, SPECT and angiography of the 60-year-old female patients in the Aurora trial. The SPECT scan appeared normal, but flurpiridaz was shown to be more sensitive and showed the ischemia from two blockages in the right coronary artery. The new radiotracer may help expand cardiac PET. #ASNC
The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) PET radiotracer agent.
READ MORE >

Tricuspid valve therapies moving ahead of mitral therapies seeking market approval

The complexity of the mitral valve has slowed development of new transcatheter technologies, and it now seems much more likely that transcatheter devices for tricuspid valve will push ahead to gain FDA clearances.

READ MORE >
Three transcatheter tricuspid valve repair and replacement (TTVR) technologies that will likely see FDA clearance in. the next couple years include the Edwards Evoque transcatheter tricuspid valve (top left), Abbott TriClip (below) and the Edwards Lifesciences Pascal clip device (right).
Share on Twitter Share on Facebook Share on Linkedin

Tricuspid valve therapies moving ahead of mitral therapies seeking market approval

Share on Twitter Share on Facebook Share on Linkedin
Three transcatheter tricuspid valve repair and replacement (TTVR) technologies that will likely see FDA clearance in. the next couple years include the Edwards Evoque transcatheter tricuspid valve (top left), Abbott TriClip (below) and the Edwards Lifesciences Pascal clip device (right).
The complexity of the mitral valve has slowed development of new transcatheter technologies, and it now seems much more likely that transcatheter devices for tricuspid valve will push ahead to gain FDA clearances.
READ MORE >

VIDEO: Trends in structural heart procedural imaging - a discussion with Rebecca Hahn

Rebecca T. Hahn, MD, Director of Interventional Echocardiography at the Columbia Structural Heart and Valve Center, discusses some of the trends in the growing use of interventional echocardiographic guidance in transcatheter structural heart procedures.

READ MORE >
Interview with Rebecca T. Hahn, MD, Professor of Medicine at Columbia University Irving Medical Center, Chief Scientific Officer of the Echo Core Lab at the Cardiovascular Research Foundation and Director of Interventional Echocardiography at the Columbia Structural Heart and Valve Center. She discusses some of the trends of growing use of interventional echocardiographic guidance in transcatheter structural heart procedures, the growing number of tricuspid valve procedures, and use of 3D ICE.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Trends in structural heart procedural imaging - a discussion with Rebecca Hahn

Share on Twitter Share on Facebook Share on Linkedin
Interview with Rebecca T. Hahn, MD, Professor of Medicine at Columbia University Irving Medical Center, Chief Scientific Officer of the Echo Core Lab at the Cardiovascular Research Foundation and Director of Interventional Echocardiography at the Columbia Structural Heart and Valve Center. She discusses some of the trends of growing use of interventional echocardiographic guidance in transcatheter structural heart procedures, the growing number of tricuspid valve procedures, and use of 3D ICE.
Rebecca T. Hahn, MD, Director of Interventional Echocardiography at the Columbia Structural Heart and Valve Center, discusses some of the trends in the growing use of interventional echocardiographic guidance in transcatheter structural heart procedures.
READ MORE >

DOACs after TAVR may put some patients at risk, new meta-analysis suggests

The new study, based on data from nearly 3,000 patients, compared DOACs such as rivaroxaban, apixaban and edoxaban with single and dual antiplatelet therapy. 

READ MORE >
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Share on Twitter Share on Facebook Share on Linkedin

DOACs after TAVR may put some patients at risk, new meta-analysis suggests

Share on Twitter Share on Facebook Share on Linkedin
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
The new study, based on data from nearly 3,000 patients, compared DOACs such as rivaroxaban, apixaban and edoxaban with single and dual antiplatelet therapy. 
READ MORE >

In Case You Missed It

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 

READ MORE >
Edward Fry, MD, is the 2022-23 ACC president.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Share on Twitter Share on Facebook Share on Linkedin
Edward Fry, MD, is the 2022-23 ACC president.
Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 
READ MORE >

VIDEO: How to build a collaborative heart team in structural heart

Brijeshwar Maini, MD, structural heart cardiologist, national and Florida medical director of cardiology, Tenant Health, explains what hospitals need to build a structural heart program and develop a heart-team care collaboration approach.

READ MORE >
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: How to build a collaborative heart team in structural heart

Share on Twitter Share on Facebook Share on Linkedin
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Brijeshwar Maini, MD, structural heart cardiologist, national and Florida medical director of cardiology, Tenant Health, explains what hospitals need to build a structural heart program and develop a heart-team care collaboration approach.
READ MORE >

VIDEO: New Technologies in Cardiac CT Imaging

Ron Blankstein, MD, Brigham and Women's Hospital, explains recent advances in coronary computed tomography angiography (CCTA) technology. 

READ MORE >
Fat attenuation index (FAI) CT imaging of coronary artery fat can show inflammation in the vessel walls and shows the residual risk of heart attacks.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: New Technologies in Cardiac CT Imaging

Share on Twitter Share on Facebook Share on Linkedin
Fat attenuation index (FAI) CT imaging of coronary artery fat can show inflammation in the vessel walls and shows the residual risk of heart attacks.
Ron Blankstein, MD, Brigham and Women's Hospital, explains recent advances in coronary computed tomography angiography (CCTA) technology. 
READ MORE >

FDA approves trial for new type of thermal-ablation system to treat ventricular arrhythmias

The FDA has approved a clinical trial to evaluate the safety and efficacy of a new type of ablation catheter for patients with ventricular tachycardia (VT) resistant to conventional anti-arrhythmic drugs or standard ablation procedures.

READ MORE >
Thermedical SERF thermal ablation system for VT.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves trial for new type of thermal-ablation system to treat ventricular arrhythmias

Share on Twitter Share on Facebook Share on Linkedin
Thermedical SERF thermal ablation system for VT.
The FDA has approved a clinical trial to evaluate the safety and efficacy of a new type of ablation catheter for patients with ventricular tachycardia (VT) resistant to conventional anti-arrhythmic drugs or standard ablation procedures.
READ MORE >

Around the Web

District Court ruling in Texas calls ACA preventive care requirement ‘unconstitutional’

The federally-appointed judge expressed concerns that volunteer experts on the U.S. Preventive Services Task Force have the power to make binding recommendations.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

District Court ruling in Texas calls ACA preventive care requirement ‘unconstitutional’

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The federally-appointed judge expressed concerns that volunteer experts on the U.S. Preventive Services Task Force have the power to make binding recommendations.
READ MORE >

The rise and fall of race-based radiation dosing: 4 lessons

Thanks to public outcry and legislative action in 1968, Black patients have not routinely received higher-dose X-rays than their fair-skinned peers for more than half a century.

READ MORE >
lyndon_johnson.jpg
Share on Twitter Share on Facebook Share on Linkedin

The rise and fall of race-based radiation dosing: 4 lessons

Share on Twitter Share on Facebook Share on Linkedin
lyndon_johnson.jpg
Thanks to public outcry and legislative action in 1968, Black patients have not routinely received higher-dose X-rays than their fair-skinned peers for more than half a century.
READ MORE >

Outsourcing reporting during out-of-hours shifts benefits staff, but is it sustainable?

Requests for urgent CT reads during the evening, overnight and on the weekends have increased more than 10-fold, causing a negative ripple effect throughout the radiology workforce, especially among trainees. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Outsourcing reporting during out-of-hours shifts benefits staff, but is it sustainable?

Share on Twitter Share on Facebook Share on Linkedin
Requests for urgent CT reads during the evening, overnight and on the weekends have increased more than 10-fold, causing a negative ripple effect throughout the radiology workforce, especially among trainees. 
READ MORE >

Monkeypox update: FDA focuses on testing as cases continue to rise

The new guidance offers a validation template that can assist test developers in submitting an Emergency Use Authorization (EUA) request. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Monkeypox update: FDA focuses on testing as cases continue to rise

Share on Twitter Share on Facebook Share on Linkedin
The new guidance offers a validation template that can assist test developers in submitting an Emergency Use Authorization (EUA) request. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme